Valuation: HemaCare Corporation

Market Cap 346M 303M 281M 258M 487M 33.36B 494M 3.35B 1.31B 16.32B 1.3B 1.27B 56.39B P/E 2017
8.18x
P/E 2018 27.6x
Enterprise Value 336M 294M 273M 251M 473M 32.4B 480M 3.25B 1.27B 15.86B 1.26B 1.23B 54.77B EV / Sales 2017
1.29x
EV / Sales 2018 4.03x
Free-Float
94.17%
Yield 2017 *
-
Yield 2018 -
Manager TitleAgeSince
Chief Executive Officer - -
Director of Finance/CFO - -
Chief Operating Officer - 2002-12-31
Director TitleAgeSince
Director/Board Member - -
Director/Board Member - -
Director/Board Member - -
Change 5-day change 1-year change 3-year change Capi.($)
+2.79%-2.86% - - 346M
-2.28%+2.05%+76.95%+42.30% 141B
-0.33%-1.84%+5.95%+30.40% 82.77B
-0.98%+6.22%+6.89%+53.04% 28.27B
+1.45%+3.99%+17.72%+45.70% 22.9B
-1.12%-0.89%-16.55%-30.12% 20.02B
-0.58%+1.56%+25.25%+154.06% 16.93B
+1.68%-4.22%+5.41%-3.95% 14.68B
-2.19%+0.20%+58.90%+127.31% 15.23B
-1.25%+0.80%-5.51%-12.53% 13.12B
Average -0.30%+2.21%+19.45%+45.13% 39.45B
Weighted average by Cap. -1.20%+3.13%+36.48%+41.56%

Financials

2017 2018
Net sales 20.21M 17.71M 16.44M 15.11M 28.47M 1.95B 28.89M 196M 76.66M 954M 75.87M 74.24M 3.3B 28.51M 24.98M 23.19M 21.31M 40.15M 2.75B 40.74M 276M 108M 1.35B 107M 105M 4.65B
Net income 4.43M 3.88M 3.61M 3.31M 6.24M 428M 6.33M 42.95M 16.81M 209M 16.64M 16.28M 723M 4.52M 3.96M 3.67M 3.38M 6.36M 436M 6.45M 43.76M 17.13M 213M 16.95M 16.59M 737M
Net Debt -9.06M -7.94M -7.37M -6.77M -12.76M -874M -12.95M -87.78M -34.36M -428M -34.01M -33.27M -1.48B -9.9M -8.67M -8.05M -7.4M -13.94M -955M -14.14M -95.9M -37.54M -467M -37.15M -36.35M -1.61B
Logo HemaCare Corporation
Charles River Laboratories Cell Solutions, Inc. is a cell sourcing provider for developers of cell therapies and basic research. The Company provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and academic institutions around the globe accelerate their research and drug development efforts. It offers a comprehensive and integrated portfolio of drug development products and services available from a single global provider, spanning the continuum from early research to the support of marketed products. Its products and services include Research Models & Services, Discovery Services Safety Assessment, Laboratory Sciences, Cell and Gene Therapy CDMO Solutions, Biologics Testing Solutions, Avian Vaccine Services, QC Microbial Solutions, Scientific & Regulatory Advisory Services, and Scientific Staffing, Training & Operations Support.
Employees
-